Name: UMIN ID:
Unique ID issued by UMIN | UMIN000043188 |
---|---|
Receipt number | R000049292 |
Scientific Title | Non-randomized prospective study to verify the usefulness and safety of olanzapine as an antiemetic in transcatheter arterial chemoembolization for hepatocellular carcinoma. |
Date of disclosure of the study information | 2021/04/01 |
Last modified on | 2024/02/12 13:10:51 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2021/01/30 18:33:37 | ||
2 | Update | 2021/01/30 18:34:57 | Anticipated trial start date |
|
3 | Update | 2021/02/27 12:56:59 | Target sample size |
|
4 | Update | 2022/01/08 20:54:40 | Date of IRB |
|
5 | Update | 2022/02/01 18:16:27 | Recruitment status |
|
6 | Update | 2022/08/13 18:46:04 | Results Delayed Results Delay Reason Results Delay Reason |
|
7 | Update | 2023/02/01 15:29:27 | Date of closure to data entry |
|
8 | Update | 2023/08/06 11:40:18 | Number of participants that the trial has enrolled |
|
9 | Update | 2024/02/12 13:10:51 | Results Results Results date posted |